Frank J. Lane
Directeur/Bestuurslid bij ALBERT LABS INTERNATIONAL CORP.
Profiel
Frank J.
Lane is the founder of Cfn Media, which was founded in 2013, where he holds the title of President.
Currently, he holds the position of Director at Albert Labs, Inc. and Albert Labs International Corp.
Additionally, he is the President & Executive Officer-CFN Media at CFN Enterprises, Inc. since 2019.
Mr. Lane received his undergraduate degree from Seattle University in 1989.
Actieve functies van Frank J. Lane
| Bedrijven | Functie | Begin |
|---|---|---|
| CFN ENTERPRISES INC. | Corporate Officer/Principal | 01-06-2019 |
| ALBERT LABS INTERNATIONAL CORP. | Directeur/Bestuurslid | - |
| Cfn Media | Oprichter | 01-01-2013 |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Directeur/Bestuurslid | - |
Opleiding van Frank J. Lane
| Seattle University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CFN ENTERPRISES INC. | Technology Services |
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Cfn Media | |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The private company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
